Deerfield Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
TCM
BI
PM
DTC
FC
SBH
DCM
Deerfield Management's LKFT Position: Q1 2025 in Review
Deerfield Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 1,411,000 shares — an estimated $38.8M sold.
Deerfield Management first reported a position in LKFT in Q2 2015 and held it in 24 quarters. The position peaked at $45.4M in Q1 2024. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.
- Deerfield Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
- Deerfield Management sold 1,411,000 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $38.8M.
- Deerfield Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 24 quarters.
- Deerfield Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $45.4M in Q1 2024.
- 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.
Based on Deerfield Management's 13F filing for Q1 2025, filed 15 May 2025.